Charts
From 02/05/2022 our Markets Data content will no longer be free to read. To continue to get full access, subscribe now and receive 25% off.
Equities

Arovella Therapeutics Ltd

Arovella Therapeutics Ltd

Actions
Health CareMedical Equipment and Services
  • Price (AUD)0.1525
  • Today's Change-0.005 / -3.17%
  • Shares traded753.94k
  • 1 Year change+106.08%
  • Beta0.2961
Data delayed at least 20 minutes, as of Sep 24 2024 06:17 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Key statistics

On Tuesday, Arovella Therapeutics Ltd (ALA:ASX) closed at 0.1525, -17.57% below its 52-week high of 0.185, set on Jul 23, 2024.
52-week range
Today
0.062Oct 04 20230.185Jul 23 2024
Open0.16
High0.16
Low0.150
Bid0.150
Offer0.155
Previous close0.1575
Average volume1.20m
Shares outstanding1.05bn
Free float729.20m
P/E (TTM)--
Market cap165.67m AUD
EPS (TTM)-0.0093
AUD
Data delayed at least 20 minutes, as of Sep 24 2024 06:17 BST.
More ▼

Events & Activity

  • ALA:ASX price falls below 50-day moving average to 0.150 at 23:50 BST
  • ALA:ASX price moved over -3.13% to 0.155
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.
S&P Global Market Intelligence Short Selling Activity © S&P Global Market Intelligence. All rights reserved.
Although S&P Global Market Intelligence has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of S&P Global Market Intelligence on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.